DE69215537D1 - t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT - Google Patents

t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT

Info

Publication number
DE69215537D1
DE69215537D1 DE69215537T DE69215537T DE69215537D1 DE 69215537 D1 DE69215537 D1 DE 69215537D1 DE 69215537 T DE69215537 T DE 69215537T DE 69215537 T DE69215537 T DE 69215537T DE 69215537 D1 DE69215537 D1 DE 69215537D1
Authority
DE
Germany
Prior art keywords
variants
specificity
fibrine
improved
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69215537T
Other languages
English (en)
Other versions
DE69215537T2 (de
Inventor
William Bennett
Bruce Keyt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69215537D1 publication Critical patent/DE69215537D1/de
Application granted granted Critical
Publication of DE69215537T2 publication Critical patent/DE69215537T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69215537T 1991-12-16 1992-12-14 t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT Expired - Lifetime DE69215537T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80812191A 1991-12-16 1991-12-16
PCT/US1992/010902 WO1993012238A1 (en) 1991-12-16 1992-12-14 t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY

Publications (2)

Publication Number Publication Date
DE69215537D1 true DE69215537D1 (de) 1997-01-09
DE69215537T2 DE69215537T2 (de) 1997-04-30

Family

ID=25197925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69215537T Expired - Lifetime DE69215537T2 (de) 1991-12-16 1992-12-14 t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT

Country Status (8)

Country Link
EP (1) EP0618973B1 (de)
JP (1) JP3696617B2 (de)
AT (1) ATE145669T1 (de)
AU (1) AU665979B2 (de)
CA (1) CA2124937C (de)
DE (1) DE69215537T2 (de)
NZ (1) NZ246467A (de)
WO (1) WO1993012238A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3112480B2 (ja) * 1991-12-16 2000-11-27 ジェネンテク，インコーポレイテッド 新規な組織プラスミノーゲン活性化因子変異体
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581652B1 (fr) * 1985-04-22 1989-12-22 Genentech Inc Nouveaux mutants de l'activateur tissulaire du plasminogene humain
NO882226L (no) * 1987-05-22 1988-11-23 Zymogenetics Inc Fibrinolytiske proteiner.

Also Published As

Publication number Publication date
NZ246467A (en) 1995-10-26
AU3324293A (en) 1993-07-19
CA2124937A1 (en) 1993-06-24
EP0618973B1 (de) 1996-11-27
CA2124937C (en) 2001-06-05
EP0618973A1 (de) 1994-10-12
WO1993012238A1 (en) 1993-06-24
JPH07501946A (ja) 1995-03-02
AU665979B2 (en) 1996-01-25
JP3696617B2 (ja) 2005-09-21
DE69215537T2 (de) 1997-04-30
ATE145669T1 (de) 1996-12-15

Similar Documents

Publication Publication Date Title
FI120348B (fi) Menetelmä terapeuttisesti käyttökelpoisen trombiini-inhibiittorin valmistamiseksi
Shimokawa et al. Sequence and Biological Activity of Catrocollastatin-C: A Disintegrin-Like/Cysteine-Rich Two-Domain Protein fromCrotalus atroxVenom
NO910811L (no) Vevsplasminogen-aktivator med zymogeniske- eller fibrinspesifikke egenskaper.
US5491129A (en) Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
WO2002048180A3 (de) Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels
AU3744889A (en) Variants of plasminogen activators and processes for their production
DE69215537D1 (de) t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT
Davis III et al. Human factor. hivin. D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequence
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
DE69105121D1 (de) Gewebeplasminogenaktivator mit fibrin-spezifischen eigenschaften.
Cierniewski et al. Localization of the cross‐linking site of GPRVVERHK in the γ‐chain of human fibrinogen
JP3277227B2 (ja) 血液凝固阻害ペプチドの製造法
DE69105213T2 (de) Substitutionsvariante des gewebeplasminogenaktivators.
JPH0618782B2 (ja) 組織プラスミノーゲン活性化因子製剤
JPH05500906A (ja) 血栓性疾患の治療
RU2049819C1 (ru) Фибрин-изопептидаза

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 618973

Country of ref document: EP